Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

SINA Corp (SINA) Will Distribute Weibo Corp (ADR) (WB) Shares

Weibo (WB) stock is up more than 140% YTD, and Sina (SINA) stock is up more than 50%. But can they continue to rally after today's news?

5 Stocks With Great Earnings Momentum — MNI CRK LEU GOL NRP

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

10 Best Cheap Stocks in the World

The market's best cheap stocks aren't blind, penny-stock dart throws. They need to have solid fundamentals and bring a little value to the table.

Intel Corporation (INTC) Is Dominating the Digital Space

Intel stock (INTC) should remain solid over the long-term, and there's potential growth in its efforts with high-performance computers.

There’s More to Johnson & Johnson (JNJ) Than Meets the Eye

Johnson & Johnson (JNJ) has an impressive pipeline most investors don't fully appreciate. This isn't your father's stock.

3 Health Care Providers & Services Stocks to Buy Now

The grades of 3 Health Care Providers & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

3 Personal Products Stocks to Buy Now

3 Personal Products stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

8 Food Products Stocks to Buy Now

The grades of 8 Food Products stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

Fitbit Inc (FIT) Tacks on Important New Services, Features

Fitbit stock (FIT) is sent higher, as the company makes moves to accelerate growth and answer its critics.

5 Thrifts & Mortgage Finance Stocks to Buy Now

This week, 5 Thrifts & Mortgage Finance stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Strong Earnings Growth — CVCY LRCX CCMP WLDN BDC

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Prime Free Cash Flow — SAEX PACD BZH NADL CREG

This week, these five stocks have the best ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

Cisco Systems, Inc.: CSCO Stock Isn’t Just About Dividends

Cisco stock has value beyond the dividends it pays. As the company shifts to fast growth segments, revenue growth could accelerate.

Walt Disney Co (DIS) Is a Well-Positioned Bargain

Disney stock (DIS) is currently trading at a discount, and it has strong long-term potential brought on by its diversification.

11 Metals & Mining Stocks to Buy Now

The grades of 11 Metals & Mining stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

8 IT Services Stocks to Buy Now

The grades of 8 IT Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

12 Health Care Equipment & Supplies Stocks to Buy Now

This week, 12 Health Care Equipment & Supplies stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Aerospace & Defense Stocks to Buy Now

This week, 5 Aerospace & Defense stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Mylan NV (MYL) Will Launch Generic EpiPens

The selloff in Mylan stock was overdone even before MYL announced EpiPen discounts and the launch of a generic alternative.